Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2 Things About AbbVie That Investors Are Ignoring
2 Things About AbbVie That Investors Are Ignoring
2 Things About AbbVie That Investors Are Ignoring
Submitted by
admin
on May 3, 2023 - 10:34pm
Source:
Motley Fool
News Tags:
AbbVie
immunology
aesthetics
Neuroscience
Headline:
2 Things About AbbVie That Investors Are Ignoring
snippet:
AbbVie’s sales of two key immunology drugs missed some analysts' estimates -- but plenty of signs point to long-term growth.
The company also is excelling in two other growth markets.
Do Not Allow Advertisers to Use My Personal information